{"id":4252,"date":"2024-02-29T12:40:22","date_gmt":"2024-02-29T11:40:22","guid":{"rendered":"http:\/\/blog.lallianse.com\/?p=4252"},"modified":"2024-10-16T11:40:51","modified_gmt":"2024-10-16T09:40:51","slug":"do-you-speak-lallianse-25-carole-neves-biotechstudio","status":"publish","type":"post","link":"https:\/\/blog.lallianse.com\/index.php\/do-you-speak-lallianse-25-carole-neves-biotechstudio\/","title":{"rendered":"Do you speak LallianSe ? #25 Carole Nev\u00e8s, BiotechStudio"},"content":{"rendered":"\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"Do you speak LallianSe ? #25 Carole Nev\u00e8s, BiotechStudio\" width=\"840\" height=\"473\" src=\"https:\/\/www.youtube.com\/embed\/n-bQz5InIQ8?list=PLCmrxoC_xfLk8NoLvPtiG9Bv7vV8jjPVM\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n\n\n\n<p class=\"has-text-color\" style=\"color:#546a7b\">D\u2019abord int\u00e9gr\u00e9e dans la <strong>#communaut\u00e9<\/strong> LallianSe au travers de nos <strong>#\u00e9v\u00e8nements<\/strong>, <a href=\"https:\/\/www.linkedin.com\/company\/11090258\/admin\/feed\/posts\/#\" target=\"_blank\" rel=\"noreferrer noopener\">Carole Neves<\/a> a rejoint notre <strong>#communaut\u00e9<\/strong> d\u2019<strong>#Experts<\/strong> en r\u00e9sidence comme Sparring et Operating partner, notamment aupr\u00e8s d\u2019<a href=\"https:\/\/www.linkedin.com\/company\/11090258\/admin\/feed\/posts\/#\" target=\"_blank\" rel=\"noreferrer noopener\">EVerZom<\/a> et de clients internationaux.<\/p>\n\n\n\n<p class=\"has-text-color\" style=\"color:#546a7b\">Notre ambition commune d\u2019accompagner la cr\u00e9ation et le d\u00e9veloppement de start-ups, combin\u00e9e \u00e0 l\u2019<strong>#expertise<\/strong> aiguis\u00e9e de <a href=\"https:\/\/www.linkedin.com\/company\/11090258\/admin\/feed\/posts\/#\" target=\"_blank\" rel=\"noreferrer noopener\">Carole<\/a> dans les maladies rares, th\u00e9rapies g\u00e9niques et autres produits innovants, nous permet d\u2019offrir une vision \u00e0 360\u00b0 des enjeux de d\u00e9veloppement des entreprises et produits de sant\u00e9.<\/p>\n\n\n\n<p class=\"has-text-color\" style=\"color:#546a7b\">In fine, c\u2019est une <strong>#synergie<\/strong> qui accompagne la cr\u00e9ation de valeur de la startup et contribue activement \u00e0 son succ\u00e8s.<\/p>\n\n\n\n<p class=\"has-text-color\" style=\"color:#546a7b\">Meet <a href=\"https:\/\/www.linkedin.com\/company\/11090258\/admin\/feed\/posts\/#\" target=\"_blank\" rel=\"noreferrer noopener\">Carole Neves<\/a>\u00e8s dans notre <strong>#\ud835\udc03\ud835\udc28\ud835\udc18\ud835\udc28\ud835\udc2e\ud835\udc12\ud835\udc29\ud835\udc1e\ud835\udc1a\ud835\udc24\ud835\udc0b\ud835\udc1a\ud835\udc25\ud835\udc25\ud835\udc22\ud835\udc1a\ud835\udc27\ud835\udc12\ud835\udc1e<\/strong>?<\/p>\n\n\n\n<p class=\"has-text-color\" style=\"color:#546a7b\">&nbsp;<strong>#sant\u00e9<\/strong> <strong>#DYSL<\/strong> <strong>#team<\/strong> <strong>#Expert<\/strong> <strong>#XIR<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>D\u2019abord int\u00e9gr\u00e9e dans la #communaut\u00e9 LallianSe au travers de nos #\u00e9v\u00e8nements, Carole Neves a rejoint notre #communaut\u00e9 d\u2019#Experts en r\u00e9sidence comme Sparring et Operating partner, notamment aupr\u00e8s d\u2019EVerZom et de clients internationaux. Notre ambition commune d\u2019accompagner la cr\u00e9ation et le d\u00e9veloppement de start-ups, combin\u00e9e \u00e0 l\u2019#expertise aiguis\u00e9e de Carole dans les maladies rares, th\u00e9rapies g\u00e9niques &hellip; <a href=\"https:\/\/blog.lallianse.com\/index.php\/do-you-speak-lallianse-25-carole-neves-biotechstudio\/\" class=\"more-link\">Continuer la lecture<span class=\"screen-reader-text\"> de &laquo;&nbsp;Do you speak LallianSe ? #25 Carole Nev\u00e8s, BiotechStudio&nbsp;&raquo;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"advanced_seo_description":"","jetpack_seo_html_title":"","jetpack_seo_noindex":false,"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"footnotes":"","_jetpack_memberships_contains_paid_content":false},"categories":[131,238],"tags":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/blog.lallianse.com\/index.php\/wp-json\/wp\/v2\/posts\/4252"}],"collection":[{"href":"https:\/\/blog.lallianse.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.lallianse.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.lallianse.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.lallianse.com\/index.php\/wp-json\/wp\/v2\/comments?post=4252"}],"version-history":[{"count":1,"href":"https:\/\/blog.lallianse.com\/index.php\/wp-json\/wp\/v2\/posts\/4252\/revisions"}],"predecessor-version":[{"id":4253,"href":"https:\/\/blog.lallianse.com\/index.php\/wp-json\/wp\/v2\/posts\/4252\/revisions\/4253"}],"wp:attachment":[{"href":"https:\/\/blog.lallianse.com\/index.php\/wp-json\/wp\/v2\/media?parent=4252"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.lallianse.com\/index.php\/wp-json\/wp\/v2\/categories?post=4252"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.lallianse.com\/index.php\/wp-json\/wp\/v2\/tags?post=4252"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}